> **WARNING: HISTORICAL / SUPERSEDED BY V3**
> This document is maintained for research provenance. For the current LIVE application provider status, refer to the V3 documents.

# POS02_PROTOCOL_CONFORMANCE_V2

## POS-02 Benchmark Construct Amendment
This document formally updates the expected protocol outcome and semantic constraints for case POS-02 ("Does statin interact with aspirin?") for the Full Gate 5 execution.

### Query
`"Does statin interact with aspirin?"`

### Accepted Evidence
- Authoritative **positive** interaction evidence.
- Authoritative **bounded-negative** interaction evidence (e.g., "No clinically significant pharmacokinetic drug-drug interactions have been observed").

### Expected System Outcome (Bounded Negative Case)
The system must retrieve the authoritative FDA label, correctly detect the relation polarity (`NEGATED`), scope (`CLINICALLY_SIGNIFICANT`), and mechanism (`PHARMACOKINETIC`), and assign it the `BOUNDED_NEGATIVE` grounding state. 
The system must generate an answer that accurately preserves this bounded scope.

### Failure Condition
A generated statement asserting an unconditional positive interaction (e.g., "Statin interacts with aspirin") derived from the bounded-negative evidence is considered a severe semantic failure.
Inferring that a bounded-negative finding (e.g., no *pharmacokinetic* interaction) proves that absolutely no interaction of any kind exists is also a failure. The generated claim must faithfully preserve the qualification present in the source text.
